REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Is Six-membered Consisting Of One Nitrogen And Five Carbon Atoms > Chalcogen Bonded Directly To Ring Carbon Of The Six-membered Hetero Ring Chalcogen Bonded Directly To Ring Carbon Of The Six-membered Hetero RingChalcogen Bonded Directly To Ring Carbon Of The Six-membered Hetero Ring patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/11/07 - 20070010563 - Novel methods for the treatment of inflammatory diseases Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) are provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine or biological activity is implicated comprising administration of compounds of formula ... 07/27/06 - 20060167064 - Pharmaceutical liquid composition containing pyridone derivative A pharmaceutical liquid composition containing the Pirfenidone in a very high concentration of more or less 25% by weight can be obtained by dissolving the Pirfenidone in diethylene glycol monoethyl ether. Even when the liquid medicinal compositions are stored for a long period of time, the Pirfenidone will not be ... 06/15/06 - 20060128762 - Medicinal composition and method for treating malignant tumor and utilization thereof The present invention provides an excellent method and a pharmaceutical composition for treating a malignant tumor, and use thereof. Specifically, the present invention is related to a pharmaceutical composition for treating malignant tumor comprising a specific aminostilbazole derivative or a pharmaceutically acceptable salt thereof, which is administered in combination with ... 05/11/06 - 20060100249 - Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses The present invention relates to compositions comprising 1,2-dihydropiridin-2-one compounds and an immunoregulatory or anti-inflammatory agent. The compositions are useful for the prevention or the treatment of neurodegenerative diseases, for example demyelinating disorders. ... 01/12/06 - 20060009496 - Method for preventing hemoprotein and heme-mediated lipid peroxidation The invention provides a method for inhibiting hemoprotein- and heme-induced lipid peroxidation, a method for identifying compositions that are effective to inhibit hemoprotein- or heme-induced lipid peroxidation, and methods of therapeutic use for those compounds. ... 12/29/05 - 20050288337 - Novel compounds The present invention relates to novel pyridone derivatives capable of inhibiting α4 integrin mediated cell adhesion, processes for their preparation, compositions comprising them and their use in the treatment of diseases capable of being modulated by the inhibition of cell adhesion. ... 12/08/05 - 20050272782 - Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1h-pyrroles and the use of these compounds for the production of pharmaceutical preparations and in related treatment methods. ... 12/08/05 - 20050272781 - Methods for the synthesis of pyridoxamine The invention also provides intermediate compounds for the synthesis of pyridoxamine, as well as compositions and methods for the treatment and/or prevention of conditions associated with the formation of post-Amadori advanced glycation end-products. ... 11/10/05 - 20050250817 - Pharmaceutical compositions of lipase-containing products, in particular of pancreation Orally administrable pharmaceutical compositions of lipase-containing products, particularly pancreatin and pancreatin-containing products, or of enzyme products which contain at least one lipase of non-animal, especially microbial origin, which improve the lipolytic activity and particularly result in stabilization of the lipase in the acidic pH range. These oral pharmaceutical compositions contain ... 11/03/05 - 20050245581 - 1, 2-dihydropyridine compounds, manufacturing method thereof and use thereof In the formula, Q indicates NH, O or S; and R1, R2, R3, R4 and R5 are the same as or different from each other and each indicates hydrogen atom, a halogen atom, a C1-6 alkyl group or a group represented by the formula —X-A (wherein X indicates a single ... 10/20/05 - 20050234108 - 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions wherein R is defined as in claim 1, the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV). ... 10/20/05 - 20050234107 - Use of diuretics for treating swellings The present invention relates to the use of a diuretic, especially a loop diuretic, for the treatment of local skin swellings. The invention further relates to pharmaceutical preparations of diuretics in topical form. ... 10/13/05 - 20050228029 - Platelet adp receptor inhibitors Novel compounds of formulae (I) to (VIII), which more particularly include sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives which are effective platelet ADP receptor inhibitors. These derivatives may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of ... 09/15/05 - 20050203148 - Organic compounds wherein R1, R2, R3, R4, R5, R6, R8, R8′, R9, W, X, A1, A2, a, b and c have the significances given in the specification, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals. ... 08/11/05 - 20050176778 - Isoprenyl derivatives and their use in the title treatment and prevention of osteoporosis and cardiovascular calcification wherein n is an integer from 1 to 14, preferably from 2 to 4, and R is an organic moiety, preferably a group different from but structurally substantially similar to 2-methyl naphthoquinone, or a group P—C(R1)—P, where each P stands for a —PO(OH)2 group and R1 is a (poly)isoprenyl group, ... 07/07/05 - 20050148638 - Compositions and methods for treating heart failure Certain substituted benzamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure. ... 06/09/05 - 20050124666 - Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same wherein R1 to R4 have the meanings stated in the claims, are suitable, for example, as antiarrhythmic medicaments with a cardioprotective component for the prophylaxis of infarction and treatment of infarction and for the treatment of angina pectoris. They also inhibit preventively the pathophysiological processes associated with the development of ... 06/09/05 - 20050124665 - Pharmaceutical compositions Compounds of formula (I) or (II), wherein R is a substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl, aralkyl aralkenyl, or aralkynyl group, that optionally includes at least one heteroatom in its carbon skeleton, and R1 is a substituted or unsubstituted, branched or straight chain alkyl, alkenyl, or alkynyl group, that ... ### FreshPatents.com Support |